Calibration and Cross-Validation of Accelerometry in Children and Adolescents with Cystic Fibrosis

Autor/inn/en	Bianchim, Mayara S.; McNarry, Melitta A.; Evans, Rachel; Thia, Lena; Barker, Alan R.; Williams, Craig A.; Denford, Sarah; Mackintosh, Kelly A
Titel	Calibration and Cross-Validation of Accelerometry in Children and Adolescents with Cystic Fibrosis
Quelle	In: Measurement in Physical Education and Exercise Science, 27 (2023) 1, S.51-59 (9 Seiten) PDF als Volltext Verfügbarkeit
Zusatzinformation	ORCID (McNarry, Melitta A.) ORCID (Barker, Alan R.) ORCID (Williams, Craig A.) ORCID (Mackintosh, Kelly A)
Sprache	englisch
Dokumenttyp	gedruckt; online; Zeitschriftenaufsatz
ISSN	1091-367X
DOI	10.1080/1091367X.2022.2065919
Schlagwörter	Genetic Disorders; Children; Early Adolescents; Physical Activity Level; Diseases; Measurement Techniques; Cutting Scores; Classification + Suchen Sie Ihr Suchwort? Child; Kind; Kinder; Disease; Krankheit; Messtechnik; Classification system; Klassifikation; Klassifikationssystem
Abstract	Commonly used cut-points may misclassify physical activity (PA) in people with cystic fibrosis (CF). The aim of this study was to develop and cross-validate condition-specific cut-points in children and adolescents with CF. Thirty-five children and adolescents with CF (15 girls; 11.6 ± 2.8 years) and 28 controls (16 girls; 12.2 ± 2.7 years), had their energy expenditure and triaxial acceleration measured during six daily activities of varying intensities. Euclidean Norm Minus One (ENMO) and Mean Amplitude Deviation (MAD) were extracted using both GENEActiv (both wrists) and ActiGraph GT9X (both wrists and right waist) accelerometers. ROC curves were used to determine healthy and CF-specific raw acceleration cut-points for sedentary time (SED), moderate physical activity (MPA) and vigorous physical activity (VPA). The PA cut-points were generally lower in CF compared to controls for both ENMO (60.2-73.1 vs. 63.5-86.8 mg) and MAD (58.9-85.2 vs. 75.9-93.7 mg). These substantial inter-cut-point differences support the need for disease-specific cut-points. (As Provided).
Anmerkungen	Routledge. Available from: Taylor & Francis, Ltd. 530 Walnut Street Suite 850, Philadelphia, PA 19106. Tel: 800-354-1420; Tel: 215-625-8900; Fax: 215-207-0050; Web site: http://www.tandf.co.uk/journals
Erfasst von	ERIC (Education Resources Information Center), Washington, DC
Update	2024/1/01